OxFORD Asset Management LLP trimmed its holdings in shares of RadNet Inc. (NASDAQ:RDNT) by 16.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 270,491 shares of the medical research company’s stock after selling 54,707 shares during the period. OxFORD Asset Management LLP owned approximately 0.57% of RadNet worth $3,111,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also bought and sold shares of RDNT. Vanguard Group Inc. raised its position in RadNet by 2.5% during the first quarter. Vanguard Group Inc. now owns 1,233,623 shares of the medical research company’s stock valued at $7,278,000 after buying an additional 30,054 shares during the period. Geode Capital Management LLC raised its position in RadNet by 6.6% during the first quarter. Geode Capital Management LLC now owns 274,192 shares of the medical research company’s stock valued at $1,617,000 after buying an additional 16,924 shares during the period. Dimensional Fund Advisors LP raised its position in RadNet by 3.2% during the first quarter. Dimensional Fund Advisors LP now owns 1,419,656 shares of the medical research company’s stock valued at $8,376,000 after buying an additional 43,960 shares during the period. Bank of America Corp DE grew its stake in RadNet by 5.9% in the first quarter. Bank of America Corp DE now owns 26,580 shares of the medical research company’s stock valued at $157,000 after purchasing an additional 1,477 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in RadNet by 3.1% in the first quarter. Goldman Sachs Group Inc. now owns 89,106 shares of the medical research company’s stock valued at $526,000 after purchasing an additional 2,684 shares in the last quarter. 53.24% of the stock is currently owned by hedge funds and other institutional investors.

In related news, Director Michael L. Md Sherman sold 8,035 shares of the stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $11.02, for a total transaction of $88,545.70. Following the completion of the sale, the director now owns 301,957 shares in the company, valued at approximately $3,327,566.14. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Michael L. Md Sherman sold 11,965 shares of the stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $11.02, for a total value of $131,854.30. Following the sale, the director now owns 289,992 shares of the company’s stock, valued at approximately $3,195,711.84. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,244,092 shares of company stock valued at $13,531,714. 9.36% of the stock is owned by corporate insiders.

RDNT has been the topic of a number of recent research reports. Zacks Investment Research downgraded RadNet from a “hold” rating to a “sell” rating in a research note on Tuesday, October 10th. Jefferies Group upgraded RadNet from a “hold” rating to a “buy” rating and upped their price target for the stock from $7.00 to $12.00 in a research note on Tuesday, August 22nd. TheStreet downgraded RadNet from a “b-” rating to a “c” rating in a research note on Friday, October 27th. Finally, BidaskClub upgraded RadNet from a “buy” rating to a “strong-buy” rating in a research note on Thursday, August 24th.

Shares of RadNet Inc. (RDNT) opened at $9.65 on Friday. RadNet Inc. has a 52 week low of $5.25 and a 52 week high of $11.90. The firm has a market capitalization of $464.33, a P/E ratio of 32.50, a P/E/G ratio of 3.28 and a beta of 0.82. The company has a debt-to-equity ratio of 7.88, a quick ratio of 1.29 and a current ratio of 1.29.

RadNet (NASDAQ:RDNT) last announced its earnings results on Thursday, November 9th. The medical research company reported $0.12 earnings per share for the quarter, meeting the consensus estimate of $0.12. RadNet had a return on equity of 23.73% and a net margin of 1.21%. The firm had revenue of $227.60 million during the quarter, compared to the consensus estimate of $232.84 million. During the same quarter in the prior year, the company earned $0.11 EPS. The firm’s revenue for the quarter was up 1.3% compared to the same quarter last year. equities analysts forecast that RadNet Inc. will post 0.35 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This article was first reported by Daily Political and is the property of of Daily Political. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://www.dailypolitical.com/2017/12/10/radnet-inc-rdnt-position-trimmed-by-oxford-asset-management-llp.html.

RadNet Profile

RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.

Institutional Ownership by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related companies with MarketBeat.com's FREE daily email newsletter.